A Controlled Study to Determine the Efficacy and Safety of CL-108 5 mg as a Treatment for Acute Pain and the Prevention of OINV

Conditions:   Pain;   Nausea;   Vomiting Interventions:   Drug: CL-108 5 mg;   Drug: Norco;   Drug: Placebo Sponsor:   Charleston Laboratories, Inc Active, not recruiting

Source: ClinicalTrials.gov - September 5, 2018 Category: Research Source Type: clinical trials